ADVENTRX Pharmaceuticals Announces Financing
... statement filed with the Securities and exchange Commission ("SEC"). A prospectus supplement ... timely required reports with the Securities and exchange Commission; the risk that ADVENTRX will trigger a ... not timely in its filings with the Securities and exchange Commission; and other risks and uncertainties ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... growth (excluding ADDERALL XR) at constant exchange rates(2) ... in 2008. (2) Sales growth at constant exchange rates ("CER"), which is a Non GAAP measure, is ... Q2 2009 results using Q2 2008 average foreign exchange rates. Angus Russell, Chief Executive ...Pharmacyclics, Inc. Rights Offering Oversubscribed
... of generating present and future income in exchange for adding to their product pipelines. ... as amended, and Section 21E of the Securities exchange Act of 1934, as amended, including statements ... section of our filings with the Securities and exchange Commission, including our annual report on Form ...Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
... in the quarter ended June 30, 2009. The change in exchange rates used to convert foreign currencies ... the effect of changes in foreign currency exchange rates, consolidated net sales decreased 0.9% for ... Europe resulting from comparatively unfavorable exchange rates. Consolidated gross margins for the quarter ...ERT Reports Second Quarter 2009 Results
... Form 10-K and 10-Q filed with the Securities and exchange Commission. Guidance is based on management's ... be made in our filings with the Securities and exchange Commission or elsewhere from time to time by, or ... ----- ------- Effect of exchange rate changes on cash 8 ...Micromet Announces Pricing of Public Offering of Common Stock
... statement filed with the Securities and exchange Commission on June 19, 2009 that became effective ... statement to be filed with the Securities and exchange Commission pursuant to Rule 462(b) promulgated ... offering will be filed with the Securities and exchange Commission. This press release shall not ...Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
... on Form 8-K filed today with the Securities and exchange Commission. Reconciliation of ... periodic reports filed with the Securities and exchange Commission, including our current reports on Form ... 31, 2008, which was filed with the Securities and exchange Commission on March 2, 2009. The forward-looking ...Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
... 8,544 18,023 20,181 Foreign exchange loss/gain 3,103 (58,347) ... 37,616 4,789,025 Foreign exchange loss/gain (49,085) 648,565 ... the meaning of Section 21E of the Securities exchange Act of 1934, as amended. Forward-looking ...Sanofi-aventis Announces Second Quarter 2009 Results
... constant Q2 reported exchange reported exchange ... EPS excluding selected items of 17.2% at constant exchange rates and 29.9% on a reported basis ... selected items of around 10% at constant exchange rates, barring major adverse events ...Zimmer Launches New Medical Education and BioSkills Training Program
... informal investigation by the U.S. Securities and exchange Commission into Foreign Corrupt Practices Act ... conditions, including interest rate and currency exchange rate fluctuations; and the costs of defending or ... reports filed with the U.S. Securities and exchange Commission. We disclaim any intention or ...Cardium Regains Listing Compliance with NYSE Amex
... now resolved matters relating to the company's exchange listing compliance. (Logo: ... by the end of the Plan Period, June 23, 2010, the exchange Staff may initiate delisting procedures. The exchange indicated that its conclusion is based upon a ...OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
... was declared effective by the Securities and exchange Commission on July 17, 2009. There was no ... offering may be obtained at the Securities and exchange Commission's web site at http://www.sec.gov , or ... in the Company's filings with the Securities and exchange Commission, including the Company's Annual Report ...Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
... on Form S-3 with the United States Securities and exchange Commission (collectively, the "Offering ... been filed with the United States Securities and exchange Commission but has not yet become effective. ... in our other filings with the Securities and exchange Commission ("SEC") and applicable Canadian ...Schering-Plough Reports Financial Results for 2009 Second Quarter
... 4 percent and an unfavorable impact from foreign exchange of 10 percent during the quarter. Net ... 4 percent and an unfavorable impact from foreign exchange of 10 percent during the quarter. Net ... growth and an unfavorable impact from foreign exchange of 10 percent. Sales of REMICADE ...Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
... global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit ... periodic reports filed with the Securities and exchange Commission, including our current reports on Form ... 31, 2008, which was filed with the Securities and exchange Commission (SEC) on February 27, 2009. The ...Pharmaxis to Voluntarily De-List from Nasdaq
... then file a Form 15F with the U.S. Securities and exchange Commission ("SEC") to terminate its registration ... primary listing on the Australian Securities exchange will continue without change. While the Company's securities will not be listed on any exchange in the United States after the deregistration ...Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
... company filed a Form 15 with the Securities and exchange Commission terminating its reporting obligations under Section 12(g) of the Securities exchange Act of 1934. As a result, the company was no ... of registrants under Section 12 of the Securities exchange Act administered by the SEC, although the ...Verenium Completes Amendment to 8% Senior Convertible Notes
... for our first commercial facility." In exchange for lowering the conversion price of the Notes ... at Verenium. The material terms of the exchange are described in more detail in the Company's ... filed on July 1, 2009 with the Securities and exchange Commission. This press release is not an offer ...Pharmaxis Closes Share Purchase Plan
... to be listed on the Australian Securities exchange on 2 July 2009. Holding statements will be ... the meaning of Section 21E of the Securities exchange Act of 1934, as amended. Forward-looking ... our Form 20-F lodged with the U.S. Securities and exchange Commission. CONTACT: Alan ...CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
... and declared effective by the Securities and exchange Commission. This press release shall not ... offering may be obtained at the Securities and exchange Commission's website at www.sec.gov . ... Act of 1933 and Section 21E of the Securities exchange Act of 1934. These statements are based on ...OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
... revenue relating to ERT's EDC business in exchange for the EDC assets of ERT which primarily include ... Act of 1933, Section 21E of the Securities exchange Act of 1934, and as that term is defined in the ... Form 10-K and 10-Q filed with the Securities and exchange Commission. The Company undertakes no obligation ...Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
... commitments of approximately $3.3 million in exchange for committed research services through Dec. 22, ... the meaning of Section 21E of the Securities exchange Act of 1934 and Section 27A of the Securities Act ... filed by Trubion with the U.S. Securities and exchange Commission. These reports are available on the ...Wyeth Announces Holder Right to Surrender Convertible Debentures
... price of the Common Stock on the New York Stock exchange on June 12, 2009, the value of the shares of ... global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit ... periodic reports filed with the Securities and exchange Commission, including our current reports on Form ...Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... statement filed with the U.S. Securities and exchange Commission became effective during the quarter. ... statement with the U.S. Securities and exchange Commission, which became effective during the ... from the global financial crisis. Foreign exchange loss The Company realized ...ADVENTRX Pharmaceuticals Announces Closing of Financing
... statement filed with the Securities and exchange Commission ("SEC"). A prospectus supplement ... which has been filed with the Securities and exchange Commission. ADVENTRX's public filings with the Securities and exchange Commission are available at www.sec.gov . ...Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
... global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit ... periodic reports filed with the Securities and exchange Commission, including our current reports on Form ... 31, 2008, which was filed with the Securities and exchange Commission on February 27, 2009. The ...ADVENTRX Pharmaceuticals Announces Financing
... statement filed with the Securities and exchange Commission ("SEC"). A prospectus supplement ... which will be filed with the Securities and exchange Commission. ADVENTRX's public filings with the Securities and exchange Commission are available at www.sec.gov . ...Document Management Inefficiencies Cost Clinical Study Sites Time, Money
... the leading provider of critical information exchange solutions. The survey revealed heavy ... traditional methods. Currently, document exchange with investigative sites is still primarily ... to securely collaborate, communicate and exchange critical information inside and outside the ...Pharmacyclics Files Registration Statement for Rights Offering
... statement on Form S-3 with the Securities and exchange Commission (the "SEC") for a rights offering to ... of generating present and future income in exchange for adding to their product pipelines. ... as amended, and Section 21E of the Securities exchange Act of 1934, as amended, including statements ...GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
... and declared effective by the Securities and exchange Commission. A prospectus supplement related to the offering will be filed with the Securities and exchange Commission (SEC). Copies of the prospectus ... company's various filings with the Securities and exchange Commission. This press release contains ...